NorthCrest Asset Manangement’s Telomir Pharmaceuticals TELO Stock Holding History

NorthCrest Asset Manangement’s Portfolio TELO Stock Details TELO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.4K	Buy	+12,119	New	+$15.8K	﹤0.01%	923

Other funds holding TELO

PWM

Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return

NorthCrest Asset Manangement's TELO Position: Q2 2026 in Review

NorthCrest Asset Manangement opened a new position in Telomir Pharmaceuticals (TELO) in Q2 2026: 12,119 shares worth $15.4K. The stake represents ﹤0.01% of the portfolio and ranks #923 among its holdings.

3 funds tracked by Wall St. Rank hold TELO as of Q2 2026.

NorthCrest Asset Manangement held 12,119 shares of Telomir Pharmaceuticals worth $15.4K as of Q2 2026.
Telomir Pharmaceuticals was a new NorthCrest Asset Manangement position in Q2 2026.
Telomir Pharmaceuticals made up ﹤0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #923 holding.
3 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.